Precision oncology company developing the next generation of biomarkers to advance cancer diagnostics with multimodal AI Platform Polaris‚Ñ¢.
StratifAI has raised $14.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2025.
StratifAI's investors include Alven, Picus Capital, Debiopharm Group, MultiplexDX, Arve Capital.
StratifAI is headquartered in Dresden, Germany.
Precision oncology company developing the next generation of biomarkers to advance cancer diagnostics with multimodal AI Platform Polaris‚Ñ¢.
StratifAI is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"StratifAI — Funding & Investors." VCBacked, September 30, 2025, https://www.vcbacked.co/company/stratifai. Accessed October 21, 2026.
VCBacked. (2025). StratifAI — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/stratifai
{{cite web |title=StratifAI — Funding & Investors |url=https://www.vcbacked.co/company/stratifai |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated